Altimmune, Inc.·4

Feb 3, 8:45 PM ET

Jordt Raymond M 4

4 · Altimmune, Inc. · Filed Feb 3, 2025

Insider Transaction Report

Form 4
Period: 2025-01-31
Jordt Raymond M
Chief Business Officer
Transactions
  • Award

    Common Stock, par value $0.0001

    2025-01-31$5.18/sh+2,614$13,54134,902 total
Footnotes (2)
  • [F1]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025.
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 1, 2024.

Documents

1 file
  • 4
    tm255357-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT